{
    "doc_id": "v1_data/DeepSeek-V3_gpqa-diamond_responses_20.json",
    "metadata": {
        "model_id": "deepseek-ai/DeepSeek-V3",
        "correct_answer": "D"
    },
    "raw_text": {
        "question": "Compounds that have the same molecular formula but are different in their structural arrangement are known as isomers. Isomers have two types, constitutional isomers and stereoisomers. Constitutional isomers have the same molecular formula but differ in their structures. In stereoisomers, molecules are connected in the same way, but their arrangements in space are different.\nAmong the given compounds (benzoquinone & cyclohexane-1,3,5-trione) the compound that does not show tautomerism (A) and among methyl 2-hydroxypropanoate and dimethyl fumarate which one will show optical isomerism (B).\nA. A = cyclohexane-1,3,5-trione, B = methyl 2-hydroxypropanoate\nB. A = benzoquinone, B = dimethyl fumarate\nC. A = cyclohexane-1,3,5-trione, B = dimethyl fumarate\nD. A = benzoquinone, B = methyl 2-hydroxypropanoate",
        "response": "To solve this problem, let's break it down step by step:\n\n### **Part A: Tautomerism**\nTautomerism is a type of isomerism where compounds can interconvert by the movement of a proton and a double bond. Compounds that can undergo tautomerism typically have a carbonyl group (C=O) adjacent to a hydrogen atom (e.g., keto-enol tautomerism).\n\n1. **Benzoquinone**: This compound has two carbonyl groups (C=O) in a quinone structure. It **cannot** undergo tautomerism because there are no hydrogen atoms adjacent to the carbonyl groups to allow for keto-enol interconversion.\n2. **Cyclohexane-1,3,5-trione**: This compound has three carbonyl groups (C=O) in a cyclic structure. It **can** undergo tautomerism because it has hydrogen atoms adjacent to the carbonyl groups, allowing for keto-enol interconversion.\n\nThus, the compound that **does not show tautomerism** is **benzoquinone**.\n\n### **Part B: Optical Isomerism**\nOptical isomerism occurs when a compound has a chiral center (a carbon atom bonded to four different groups) and is non-superimposable on its mirror image.\n\n1. **Methyl 2-hydroxypropanoate**: This compound has a chiral center (the carbon bonded to -OH, -COOCH\u2083, -CH\u2083, and -H). It **can** show optical isomerism.\n2. **Dimethyl fumarate**: This compound is a trans-alkene with no chiral centers. It **cannot** show optical isomerism.\n\nThus, the compound that **shows optical isomerism** is **methyl 2-hydroxypropanoate**.\n\n### **Final Answer**\nThe correct option is:\n**D. A = benzoquinone, B = methyl 2-hydroxypropanoate**"
    },
    "nodes": [
        {
            "id": "ctx0",
            "annotation": false,
            "start": 0,
            "end": 119,
            "label": "context",
            "text": "Compounds that have the same molecular formula but are different in their structural arrangement are known as isomers. ",
            "source": "question"
        },
        {
            "id": "ctx1",
            "annotation": false,
            "start": 119,
            "end": 185,
            "label": "context",
            "text": "Isomers have two types, constitutional isomers and stereoisomers. ",
            "source": "question"
        },
        {
            "id": "ctx2",
            "annotation": false,
            "start": 185,
            "end": 272,
            "label": "context",
            "text": "Constitutional isomers have the same molecular formula but differ in their structures. ",
            "source": "question"
        },
        {
            "id": "ctx3",
            "annotation": false,
            "start": 272,
            "end": 378,
            "label": "context",
            "text": "In stereoisomers, molecules are connected in the same way, but their arrangements in space are different.\n",
            "source": "question"
        },
        {
            "id": "ctx4",
            "annotation": false,
            "start": 378,
            "end": 596,
            "label": "context",
            "text": "Among the given compounds (benzoquinone & cyclohexane-1,3,5-trione) the compound that does not show tautomerism (A) and among methyl 2-hydroxypropanoate and dimethyl fumarate which one will show optical isomerism (B).\n",
            "source": "question"
        },
        {
            "id": "ctx5",
            "annotation": false,
            "start": 596,
            "end": 599,
            "label": "context",
            "text": "A. ",
            "source": "question"
        },
        {
            "id": "ctx6",
            "annotation": false,
            "start": 599,
            "end": 663,
            "label": "context",
            "text": "A = cyclohexane-1,3,5-trione, B = methyl 2-hydroxypropanoate\nB. ",
            "source": "question"
        },
        {
            "id": "ctx7",
            "annotation": false,
            "start": 663,
            "end": 809,
            "label": "context",
            "text": "A = benzoquinone, B = dimethyl fumarate\nC. A = cyclohexane-1,3,5-trione, B = dimethyl fumarate\nD. A = benzoquinone, B = methyl 2-hydroxypropanoate",
            "source": "question"
        },
        {
            "id": "resp0",
            "annotation": false,
            "start": 0,
            "end": 58,
            "label": "planning",
            "text": "To solve this problem, let's break it down step by step:\n\n",
            "source": "response"
        },
        {
            "id": "resp1",
            "annotation": false,
            "start": 58,
            "end": 86,
            "label": "planning",
            "text": "### **Part A: Tautomerism**\n",
            "source": "response"
        },
        {
            "id": "resp2",
            "annotation": false,
            "start": 86,
            "end": 201,
            "label": "fact",
            "text": "Tautomerism is a type of isomerism where compounds can interconvert by the movement of a proton and a double bond. ",
            "source": "response"
        },
        {
            "id": "resp3",
            "annotation": false,
            "start": 201,
            "end": 338,
            "label": "fact",
            "text": "Compounds that can undergo tautomerism typically have a carbonyl group (C=O) adjacent to a hydrogen atom (e.g., keto-enol tautomerism).\n\n",
            "source": "response"
        },
        {
            "id": "resp4",
            "annotation": false,
            "start": 338,
            "end": 427,
            "label": "fact",
            "text": "1. **Benzoquinone**: This compound has two carbonyl groups (C=O) in a quinone structure. ",
            "source": "response"
        },
        {
            "id": "resp5",
            "annotation": false,
            "start": 427,
            "end": 569,
            "label": "reasoning",
            "text": "It **cannot** undergo tautomerism because there are no hydrogen atoms adjacent to the carbonyl groups to allow for keto-enol interconversion.\n",
            "source": "response"
        },
        {
            "id": "resp6",
            "annotation": false,
            "start": 569,
            "end": 671,
            "label": "fact",
            "text": "2. **Cyclohexane-1,3,5-trione**: This compound has three carbonyl groups (C=O) in a cyclic structure. ",
            "source": "response"
        },
        {
            "id": "resp7",
            "annotation": false,
            "start": 671,
            "end": 806,
            "label": "reasoning",
            "text": "It **can** undergo tautomerism because it has hydrogen atoms adjacent to the carbonyl groups, allowing for keto-enol interconversion.\n\n",
            "source": "response"
        },
        {
            "id": "resp8",
            "annotation": false,
            "start": 806,
            "end": 882,
            "label": "reasoning",
            "text": "Thus, the compound that **does not show tautomerism** is **benzoquinone**.\n\n",
            "source": "response"
        },
        {
            "id": "resp9",
            "annotation": false,
            "start": 882,
            "end": 916,
            "label": "planning",
            "text": "### **Part B: Optical Isomerism**\n",
            "source": "response"
        },
        {
            "id": "resp10",
            "annotation": false,
            "start": 916,
            "end": 1073,
            "label": "fact",
            "text": "Optical isomerism occurs when a compound has a chiral center (a carbon atom bonded to four different groups) and is non-superimposable on its mirror image.\n\n",
            "source": "response"
        },
        {
            "id": "resp11",
            "annotation": false,
            "start": 1073,
            "end": 1193,
            "label": "fact",
            "text": "1. **Methyl 2-hydroxypropanoate**: This compound has a chiral center (the carbon bonded to -OH, -COOCH\u2083, -CH\u2083, and -H). ",
            "source": "response"
        },
        {
            "id": "resp12",
            "annotation": false,
            "start": 1193,
            "end": 1228,
            "label": "reasoning",
            "text": "It **can** show optical isomerism.\n",
            "source": "response"
        },
        {
            "id": "resp13",
            "annotation": false,
            "start": 1228,
            "end": 1310,
            "label": "fact",
            "text": "2. **Dimethyl fumarate**: This compound is a trans-alkene with no chiral centers. ",
            "source": "response"
        },
        {
            "id": "resp14",
            "annotation": false,
            "start": 1310,
            "end": 1349,
            "label": "reasoning",
            "text": "It **cannot** show optical isomerism.\n\n",
            "source": "response"
        },
        {
            "id": "resp15",
            "annotation": false,
            "start": 1349,
            "end": 1437,
            "label": "reasoning",
            "text": "Thus, the compound that **shows optical isomerism** is **methyl 2-hydroxypropanoate**.\n\n",
            "source": "response"
        },
        {
            "id": "resp16",
            "annotation": false,
            "start": 1437,
            "end": 1458,
            "label": "planning",
            "text": "### **Final Answer**\n",
            "source": "response"
        },
        {
            "id": "resp17",
            "annotation": false,
            "start": 1458,
            "end": 1481,
            "label": "restatement",
            "text": "The correct option is:\n",
            "source": "response"
        },
        {
            "id": "resp18",
            "annotation": false,
            "start": 1481,
            "end": 1536,
            "label": "conclusion",
            "text": "**D. A = benzoquinone, B = methyl 2-hydroxypropanoate**",
            "source": "response"
        }
    ],
    "edges": [
        {
            "id": "e0",
            "from_node_id": "ctx4",
            "to_node_id": "resp0",
            "label": "plan:frontier-plan"
        },
        {
            "id": "e1",
            "from_node_id": "ctx5",
            "to_node_id": "resp0",
            "label": "plan:frontier-plan"
        },
        {
            "id": "e2",
            "from_node_id": "ctx6",
            "to_node_id": "resp0",
            "label": "plan:frontier-plan"
        },
        {
            "id": "e3",
            "from_node_id": "ctx7",
            "to_node_id": "resp0",
            "label": "plan:frontier-plan"
        },
        {
            "id": "e4",
            "from_node_id": "resp0",
            "to_node_id": "resp1",
            "label": "plan:plan-subplan"
        },
        {
            "id": "e5",
            "from_node_id": "resp1",
            "to_node_id": "resp2",
            "label": "reason:plan-step"
        },
        {
            "id": "e6",
            "from_node_id": "resp2",
            "to_node_id": "resp3",
            "label": "reason:fact-detail"
        },
        {
            "id": "e7",
            "from_node_id": "resp3",
            "to_node_id": "resp4",
            "label": "reason:fact-detail"
        },
        {
            "id": "e8",
            "from_node_id": "resp2",
            "to_node_id": "resp5",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e9",
            "from_node_id": "resp3",
            "to_node_id": "resp5",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e10",
            "from_node_id": "resp4",
            "to_node_id": "resp5",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e11",
            "from_node_id": "resp1",
            "to_node_id": "resp6",
            "label": "reason:plan-step"
        },
        {
            "id": "e12",
            "from_node_id": "resp5",
            "to_node_id": "resp6",
            "label": "reason:fact-detail"
        },
        {
            "id": "e13",
            "from_node_id": "resp5",
            "to_node_id": "resp7",
            "label": "evaluate:refute"
        },
        {
            "id": "e14",
            "from_node_id": "resp6",
            "to_node_id": "resp7",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e15",
            "from_node_id": "resp4",
            "to_node_id": "resp8",
            "label": "reason:fact-detail"
        },
        {
            "id": "e16",
            "from_node_id": "resp5",
            "to_node_id": "resp8",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e17",
            "from_node_id": "resp6",
            "to_node_id": "resp8",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e18",
            "from_node_id": "resp7",
            "to_node_id": "resp8",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e19",
            "from_node_id": "resp0",
            "to_node_id": "resp9",
            "label": "plan:plan-nextplan"
        },
        {
            "id": "e20",
            "from_node_id": "resp9",
            "to_node_id": "resp10",
            "label": "reason:plan-step"
        },
        {
            "id": "e21",
            "from_node_id": "resp10",
            "to_node_id": "resp11",
            "label": "reason:fact-detail"
        },
        {
            "id": "e22",
            "from_node_id": "resp11",
            "to_node_id": "resp12",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e23",
            "from_node_id": "resp12",
            "to_node_id": "resp13",
            "label": "reason:fact-detail"
        },
        {
            "id": "e24",
            "from_node_id": "resp13",
            "to_node_id": "resp14",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e25",
            "from_node_id": "resp14",
            "to_node_id": "resp14",
            "label": "evaluate:support"
        },
        {
            "id": "e26",
            "from_node_id": "resp11",
            "to_node_id": "resp15",
            "label": "reason:fact-detail"
        },
        {
            "id": "e27",
            "from_node_id": "resp12",
            "to_node_id": "resp15",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e28",
            "from_node_id": "resp9",
            "to_node_id": "resp16",
            "label": "plan:plan-nextplan"
        },
        {
            "id": "e29",
            "from_node_id": "resp15",
            "to_node_id": "resp16",
            "label": "plan:frontier-plan"
        },
        {
            "id": "e30",
            "from_node_id": "resp15",
            "to_node_id": "resp17",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e31",
            "from_node_id": "resp16",
            "to_node_id": "resp17",
            "label": "reason:plan-step"
        },
        {
            "id": "e32",
            "from_node_id": "resp8",
            "to_node_id": "resp18",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e33",
            "from_node_id": "resp15",
            "to_node_id": "resp18",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e34",
            "from_node_id": "resp16",
            "to_node_id": "resp18",
            "label": "reason:plan-step"
        },
        {
            "id": "e35",
            "from_node_id": "resp17",
            "to_node_id": "resp18",
            "label": "reason:stmt-restatement"
        }
    ]
}